London-based Causaly, which uses AI for biomedical research and drug discovery, raised a $60M Series B led by ICONIQ Growth, taking its total funding to $93M (Ingrid Lunden/TechCrunch)



Ingrid Lunden / TechCrunch:

London-based Causaly, which uses AI for biomedical research and drug discovery, raised a $60M Series B led by ICONIQ Growth, taking its total funding to $93M  —  Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery.



About WN

Check Also

U.K. orders Apple to let it spy on users’ encrypted accounts

Secret order requires blanket access to protected cloud backups around the world, which if implemented …

Advertisment ad adsense adlogger